EARNANO, LLC

Biotech · Private

Topical eardrop formulation combining antimicrobial peptides, innate immune modulators, and antibiotic/corticosteroid for otitis media treatment

Grants
$218K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Targeting bacteria, the innate response of the middle ear to infection, and host-pathogen interactions, using topical and transtympanic applications for the treatment of otitis media.$217,605
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3004Structure Therapeutics——
3005Provivi Inc.—$77M
3006REVERSAL THERAPEUTICS INC——
3007EARNANO, LLC——
3008SPEKCITON BIOSCIENCES LLC——
3009MONTANA MOLECULAR, LLC——
3010ARGOS VISION INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.